Home » SEC Filing Articles

Image for Field & Main Bank Decreases Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Field & Main Bank Decreases Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Field & Main Bank lessened its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 12,595 shares... More of this article »
Image for Field & Main Bank Buys 200 Shares of Visa Inc. (NYSE:V)

Field & Main Bank Buys 200 Shares of Visa Inc. (NYSE:V)

Field & Main Bank boosted its stake in Visa Inc. (NYSE:V – Free Report) by 1.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,189 shares... More of this article »
Image for International Business Machines Co. (NYSE:IBM) Stake Reduced by Field & Main Bank

International Business Machines Co. (NYSE:IBM) Stake Reduced by Field & Main Bank

Field & Main Bank cut its holdings in shares of International Business Machines Co. (NYSE:IBM – Free Report) by 1.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange... More of this article »
Image for Tower Research Capital LLC TRC Sells 7,804 Shares of iShares U.S. Tech Independence Focused ETF (BATS:IETC)

Tower Research Capital LLC TRC Sells 7,804 Shares of iShares U.S. Tech Independence Focused ETF (BATS:IETC)

Tower Research Capital LLC TRC reduced its holdings in iShares U.S. Tech Independence Focused ETF (BATS:IETC – Free Report) by 89.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange... More of this article »
Image for Tower Research Capital LLC TRC Has $60,000 Stock Position in Revance Therapeutics, Inc. (NASDAQ:RVNC)

Tower Research Capital LLC TRC Has $60,000 Stock Position in Revance Therapeutics, Inc. (NASDAQ:RVNC)

Tower Research Capital LLC TRC boosted its holdings in shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 626.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission.... More of this article »